ENZO BIOCHEM INC Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q3 2014 to Q1 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Enzo Biochem Inc quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q3 2014 to Q1 2024.
  • Enzo Biochem Inc Weighted Average Number of Shares Outstanding, Diluted for the quarter ending April 30, 2024 was 51.2K shares, a 3.71% increase year-over-year.
  • Enzo Biochem Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 49.2K shares, a 1.17% increase from 2022.
  • Enzo Biochem Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 48.6K shares, a 0.56% increase from 2021.
  • Enzo Biochem Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 48.3K shares, a 1.32% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 51.2K +1.83K +3.71% Feb 1, 2024 Apr 30, 2024 10-Q 2024-06-13
Q4 2023 50.5K +1.76K +3.61% Nov 1, 2023 Jan 31, 2024 10-Q 2024-03-13
Q3 2023 50.2K +1.46K +3.01% Aug 1, 2023 Oct 31, 2023 10-Q 2023-12-15
Q2 2023 49.2K +566 +1.17% May 1, 2023 Jul 31, 2023 10-K 2023-11-03
Q1 2023 49.4K +671 +1.38% Feb 1, 2023 Apr 30, 2023 10-Q 2024-06-13
Q4 2022 48.7K +257 +0.53% Nov 1, 2022 Jan 31, 2023 10-Q 2024-03-13
Q3 2022 48.7K +248 +0.51% Aug 1, 2022 Oct 31, 2022 10-Q 2023-12-15
Q2 2022 48.6K +269 +0.56% May 1, 2022 Jul 31, 2022 10-K 2023-11-03
Q1 2022 48.7K -75 -0.15% Feb 1, 2022 Apr 30, 2022 10-Q 2023-06-14
Q4 2021 48.5K +419 +0.87% Nov 1, 2021 Jan 31, 2022 10-Q 2023-03-20
Q3 2021 48.5K +567 +1.18% Aug 1, 2021 Oct 31, 2021 10-Q 2022-12-12
Q2 2021 48.3K +629 +1.32% May 1, 2021 Jul 31, 2021 10-K 2022-10-14
Q1 2021 48.8K +1.01K +2.11% Feb 1, 2021 Apr 30, 2021 10-Q 2022-06-09
Q4 2020 48.1K +496 +1.04% Nov 1, 2020 Jan 31, 2021 10-Q 2022-03-14
Q3 2020 47.9K +348 +0.73% Aug 1, 2020 Oct 31, 2020 10-Q 2021-12-15
Q2 2020 47.7K May 1, 2020 Jul 31, 2020 10-K 2022-10-14
Q1 2020 47.8K +225 +0.47% Feb 1, 2020 Apr 30, 2020 10-Q 2021-06-11
Q4 2019 47.6K Nov 1, 2019 Jan 31, 2020 10-Q 2021-03-16
Q3 2019 47.6K Aug 1, 2019 Oct 31, 2019 10-Q 2020-12-11
Q1 2019 47.6K -47M -99.9% Feb 1, 2019 Apr 30, 2019 10-Q 2020-06-09
Q1 2018 47.1M* +706K +1.52% Feb 1, 2018 Apr 30, 2018 10-Q 2019-06-10
Q3 2017 46.9M* +642K +1.39% Aug 1, 2017 Oct 31, 2017 10-Q 2017-12-07
Q1 2017 46.4M* +166K +0.36% Feb 1, 2017 Apr 30, 2017 10-Q 2017-06-08
Q4 2016 46.3M* -226K -0.49% Nov 1, 2016 Jan 31, 2017 10-Q 2017-03-13
Q3 2016 46.3M* +79K +0.17% Aug 1, 2016 Oct 31, 2016 10-Q 2017-12-07
Q1 2016 46.2M* +404K +0.88% Feb 1, 2016 Apr 30, 2016 10-Q 2017-06-08
Q4 2015 46.5M* +1.52M +3.37% Nov 1, 2015 Jan 31, 2016 10-Q 2017-03-13
Q3 2015 46.2M* +1.63M +3.66% Aug 1, 2015 Oct 31, 2015 10-Q 2016-12-08
Q1 2015 45.8M* Feb 1, 2015 Apr 30, 2015 10-Q 2016-06-08
Q4 2014 45M* Nov 1, 2014 Jan 31, 2015 10-Q 2016-03-09
Q3 2014 44.6M* Aug 1, 2014 Oct 31, 2014 10-Q 2015-12-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.